Imaging for acute low back pain without specific No evidence to support that indications. (American Society of this condition requires Anesthesiologists - Pain Medicine) imaging. Doing so many reveal incidental findings that diverts attention and increases risk of unnecessary surgery.4 Appendix C: Positron Emission Tomography (PET) Use Description Rationale Routine PET-CT in the initial staging of Increases cost without Cancer localized colon or rectal cancer or as part of improved outcomes.19 Staging and routine surveillance for patients who have been Surveillance curatively treated for colon or rectal cancer Testing (Society of Surgical Oncology) Routinely ordering [PET/CT] imaging studies Does not significantly for staging purposes on patients newly improve staging while diagnosed with localized primary cutaneous increasing risk of false melanoma unless there is suspicion for positives leading to metastatic disease based on history and physical unnecessary and potentially exam (Society of Surgical Oncology) harmful treatment.19 Surveillance testing (biomarkers) or imaging No benefit with risk of false (PET, CT, and radionuclide bone scans) for positives.19 asymptomatic individuals who have been treated for breast cancer with curative intent (American Society of Clinical Oncology) PET, CT, and radionuclide bone scans in the Lack of evidence suggesting staging of early breast cancer or early prostate this screening improves cancer at low risk for metastasis (American detection of metastatic disease Society of Clinical Oncology) or survival.19 Diagnostic or surveillance tool for recurrent or Evidence suggests the use of Cancer persistent cervical cancer. PET is not cost effective.33 Staging and
Imaging for acute low back pain without specific indications. (American Society of Anesthesiologists - Pain Medicine) No evidence to support that this condition requires imaging. Doing so many reveal incidental findings that diverts attention and increases risk of unnecessary surgery.4 Appendix C: Positron Emission Tomography (PET) Use Description Rationale Cancer Staging and Surveillance Testing Routine PET-CT in the initial staging of localized colon or rectal cancer or as part of routine surveillance for patients who have been curatively treated for colon or rectal cancer (Society of Surgical Oncology) Increases cost without improved outcomes.19 Routinely ordering [PET/CT] imaging studies for staging purposes on patients newly diagnosed with localized primary cutaneous melanoma unless there is suspicion for metastatic disease based on history and physical exam (Society of Surgical Oncology) Does not significantly improve staging while increasing risk of false positives leading to unnecessary and potentially harmful treatment.19 Surveillance testing (biomarkers) or imaging (PET, CT, and radionuclide bone scans) for asymptomatic individuals who have been treated for breast cancer with curative intent (American Society of Clinical Oncology) No benefit with risk of false positives.19 PET, CT, and radionuclide bone scans in the staging of early breast cancer or early prostate cancer at low risk for metastasis (American Society of Clinical Oncology) Lack of evidence suggesting this screening improves detection of metastatic disease or survival.19 Cancer Staging and Diagnostic or surveillance tool for recurrent or persistent cervical cancer. Evidence suggests the use of PET is not cost effective.33